Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage
Cells · 16.09.2024 · 13 (18) · 1560
DOI: 10.3390/cells13181560 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 16.09.2024. Verfasst von Biki Saha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biotechnology, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institu…. Hauptthemen laut MEDLINE: Biomarkers, Liver Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of General Medical Sciences (NIGMS).
Abstract (Originalsprache)
Highly conformal delivery of radiation therapy (RT) has revolutionized the treatment landscape for primary and metastatic liver cancers, yet concerns persist regarding radiation-induced liver disease (RILD). Despite advancements, RILD remains a major dose-limiting factor due to the potential damage to normal liver tissues by therapeutic radiation. The toxicity to normal liver tissues is associated with a multitude of physiological and pathological consequences. RILD unfolds as multifaceted processes, intricately linking various responses, such as DNA damage, oxidative stress, inflammation, cellular senescence, fibrosis, and immune reactions, through multiple signaling pathways. The DNA damage caused by ionizing radiation (IR) is a major contributor to the pathogenesis of RILD. Moreover, current treatment options for RILD are limited, with no established biomarker for early detection. RILD diagnosis often occurs at advanced stages, highlighting the critical need for early biomarkers to adjust treatment strategies and prevent liver failure. This review provides an outline of the diverse molecular and cellular mechanisms responsible for the development of RILD and points out all of the available biomarkers for early detection with the aim of helping clinicians decide on advance treatment strategies from a single literature recourse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Biotechnology, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Chennai 603103, India.
- R&D, Genomic Bio-Medicine Research and Incubation (GBMRI), Durg 491001, Chhattisgarh, India.
- Division of Radiation Health, Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
ORCID-Profile: Sneha Pallatt, Abhijit G Banerjee, Rupak Pathak
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute of General Medical Sciences (NIGMS)
- National Institute of Allergy and Infectious Diseases (NIAID)
- NASA-EPSCoR
Zitieren
APA
Saha, B., Pallatt, S., Banerjee, A., Banerjee, A. G., Pathak, R., & Pathak, S. (2024). Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage. Cells, 13(18), 1560. https://doi.org/10.3390/cells13181560
Vancouver
Saha B, Pallatt S, Banerjee A, Banerjee AG, Pathak R, Pathak S. Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage. Cells. 2024;13(18):1560. doi:10.3390/cells13181560
BibTeX
@article{Saha2024,
author = {Saha, Biki and Pallatt, Sneha and Banerjee, Antara and Banerjee, Abhijit G and Pathak, Rupak and Pathak, Surajit},
title = {Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage},
journal = {Cells},
year = {2024},
volume = {13},
number = {18},
pages = {1560},
doi = {10.3390/cells13181560}
}
EUVIMED